Abstract

Plasmodium vivax malaria traditionally thought to be benign, nowadays is often diagnosed in patients with a myriad of systemic complications like cerebral malaria, acute respiratory distress syndrome, acute kidney injury, acute pancreatitis, hepatic dysfunction, disseminated intravascular coagulation, etc which were earlier attributed only to plasmodium falciparum. Hence timely intervention and expert care should be undertaken for vivax patients so that the mortality and morbidity associated with this form of malaria can be reduced.